Dataset: Transcription profiling of rat heart samples from animals with cardiac hypertrophy induced by aortic banding, myocardial infarction, av-fistula or hormone infusion
Cardiac hypertrophy was induced by aortic banding (6, 12, 16, and 30 weeks), myocardial infarction (3 and 9 weeks), an av-fistula (aorta...
Cardiac hypertrophy was induced by aortic banding (6, 12, 16, and 30 weeks), myocardial infarction (3 and 9 weeks), an av-fistula (aorta abd. to v. cava inf.. 3 and 8 weeks), or hormone infusion (two weeks either angiotensin 2 or a thyroxin analogue). Sham operated or saline infused animals served as controls. Gene expression was determined by Affymetrix RGU34A GeneChip's to identify genes with common regulation in the different models of cardiac hypertrophy.
- Species:
- rat
- Samples:
- 46
- Source:
- E-GEOD-738
- Updated:
- Feb.09, 2015
- Registered:
- Jan.11, 2015
Factors:
(via ArrayExpress)
Sample | ClinicalTreatment | DiseaseState | Time |
---|---|---|---|
GSE738GSM11184 | aortic banding | cardiac hypertrophy | 12 |
GSE738GSM11184 | aortic banding | cardiac hypertrophy | 12 |
GSE738GSM11182 | aortic banding - sham | normal | 12 |
GSE738GSM11182 | aortic banding - sham | normal | 12 |
GSE738GSM11188 | aortic banding | cardiac hypertrophy | 16 |
GSE738GSM11188 | aortic banding | cardiac hypertrophy | 16 |
GSE738GSM11186 | aortic banding - sham | normal | 16 |
GSE738GSM11186 | aortic banding - sham | normal | 16 |
GSE738GSM11192 | aortic banding | cardiac hypertrophy | 30 |
GSE738GSM11192 | aortic banding | cardiac hypertrophy | 30 |
GSE738GSM11192 | aortic banding | cardiac hypertrophy | 30 |
GSE738GSM11192 | aortic banding | cardiac hypertrophy | 30 |
GSE738GSM11190 | aortic banding - sham | normal | 30 |
GSE738GSM11190 | aortic banding - sham | normal | 30 |
GSE738GSM11180 | aortic banding | cardiac hypertrophy | 6 |
GSE738GSM11180 | aortic banding | cardiac hypertrophy | 6 |
GSE738GSM11178 | aortic banding - sham | normal | 6 |
GSE738GSM11178 | aortic banding - sham | normal | 6 |
GSE738GSM11198 | infusion of angiotensin 2 | cardiac hypertrophy | 2 |
GSE738GSM11198 | infusion of angiotensin 2 | cardiac hypertrophy | 2 |
GSE738GSM11200 | infusion of thyroxin analogue | cardiac hypertrophy | 2 |
GSE738GSM11200 | infusion of thyroxin analogue | cardiac hypertrophy | 2 |
GSE738GSM11166 | myocardial infarction - sham | normal | 3 |
GSE738GSM11166 | myocardial infarction - sham | normal | 3 |
GSE738GSM11168 | myocardial infarction | cardiac hypertrophy | 3 |
GSE738GSM11168 | myocardial infarction | cardiac hypertrophy | 3 |
GSE738GSM11168 | myocardial infarction | cardiac hypertrophy | 3 |
GSE738GSM11168 | myocardial infarction | cardiac hypertrophy | 3 |
GSE738GSM11174 | myocardial infarction | cardiac hypertrophy | 9 |
GSE738GSM11174 | myocardial infarction | cardiac hypertrophy | 9 |
GSE738GSM11174 | myocardial infarction | cardiac hypertrophy | 9 |
GSE738GSM11174 | myocardial infarction | cardiac hypertrophy | 9 |
GSE738GSM11172 | myocardial infarction - sham | normal | 9 |
GSE738GSM11172 | myocardial infarction - sham | normal | 9 |
GSE738GSM11202 | none | normal | |
GSE738GSM11202 | none | normal | |
GSE738GSM11160 | av-fistula | cardiac hypertrophy | 3 |
GSE738GSM11160 | av-fistula | cardiac hypertrophy | 3 |
GSE738GSM11159 | av-fistula - sham | normal | 3 |
GSE738GSM11159 | av-fistula - sham | normal | 3 |
GSE738GSM11164 | av-fistula | cardiac hypertrophy | 8 |
GSE738GSM11164 | av-fistula | cardiac hypertrophy | 8 |
GSE738GSM11162 | av-fistula - sham | normal | 8 |
GSE738GSM11162 | av-fistula - sham | normal | 8 |
GSE738GSM11196 | infusion of saline | normal | 2 |
GSE738GSM11196 | infusion of saline | normal | 2 |